Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 09/03/2012
PIL IntronA 25 million IU/2.5ml solution for injection or infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 21/02/2012 and displayed until 09/03/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to information about pregnancy or lactation
Updated on 30/08/2011 and displayed until 21/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
Updated on 25/10/2010 and displayed until 30/08/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
  • Change to side-effects
  • Extra statutory information
Updated on 26/01/2010 and displayed until 25/10/2010
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  interferon alfa-2b